(-(2-Thienyl)-Ala58,D-Phe7)-Bradykinin

DRUG PEPTIDES

CAT No.# CS-AX-00055
Category Drug Peptides
CAS 97825-07-5
Stock Status
AVAILABLE ENQUIRE NOW View COA

(Available within 3-5 days)

Product maybe under re-certification or re-stock. Enquire now to know exact date of delivery and pricing.
Molecular Weight 1122.32
Molecular Formula C50H71N15O11S2
Purity: >98%
Synonyms: (2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-(2-{[(2S)-1-[(2S)-1-[(2S)-2-amino-5-[(diaminomethylidene)amino]pentanoyl]pyrrolidine-2-carbonyl]pyrrolidin-2-yl]formamido}acetamido)-3-(thiophen-2-yl)propanamido]-3-hydroxypropanamido]-3-phenylpropanamido]-3-(thiophen-2-yl)propanamido]-5-[(diaminomethylidene)amino]pentanoic acid
References: J. Vavrek and J.M. Stewart, Peptides, 6, 161 (1985)
Shipping: Free Shipping for worldwide on order above 2000 USD
(-(2-Thienyl)-Ala58,D-Phe7)-Bradykinin Worldwide Suppliers of (-(2-Thienyl)-Ala58,D-Phe7)-Bradykinin Drug Peptides Clearsynth CS-AX-00055

Product rating: 9 (-(2-Thienyl)-Ala58,D-Phe7)-Bradykinin based on 20 ratings

  1. Drug Peptides
  2. (-(2-Thienyl)-Ala58,D-Phe7)-Bradykinin


PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
6. BISPHENOL AF (RING-13C12)
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. Silodosin Metabolite
11. 2-Phenoxymethanesulfonanilide
12. Nimesulide EP Impurity A
13. Acetone HPLC
14. Riluzole (1604337)
15. Pheniramine impurity B
16. Palbociclib N-Glucuronide
17. Carpropamid
18. Olmesartan N1-Trityl Impurity
19. 1-Octadecanethiol
20. H-Ser(Bzl)-OBzl . p-tosylate (E-3755.0005)


This page contains information about (-(2-Thienyl)-Ala58,D-Phe7)-Bradykinin Cas 97825-07-5 and its Drug Peptides.

(-(2-Thienyl)-Ala58,D-Phe7)-Bradykinin (-(2-Thienyl)-Ala58,D-Phe7)-Bradykinin Worldwide Suppliers of (-(2-Thienyl)-Ala58,D-Phe7)-Bradykinin Drug Peptides Clearsynth 97825-07-5

"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."